Mutagenic Potential of Nitroguanidine in the Mouse Lymphoma Forward Mutation Assay
Abstract
The mutagenic potential of nitroguanidine was assessed in the mouse lymphoma thymidine kinase forward mutation assay both with and without metabolic activation by rat liver. In the initial range-finding assay, cells were exposed to test compound concentrations ranging from 4 milligram/milliliter to 0.01 milligram/milliliter. The confirmatory assay employed doses from 4 milligram/ milliliter to 1 milligram/milliliter. Nitroguanidine did not induce a statistically significant increase in the mutant frequency in either of the two assays. These results indicate that nitroguanidine was not mutagenic under the conditions of this study. Keywords: Mutagenicity, Genetic toxicology, Mouse lymphoma assay, Mutagenesis, In vitro, Nitroguanidine; teratology; Toxic tolerances.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 01, 1987
- Accession Number
- ADA190926
Entities
People
- Don W. Korte Jr.
- John W. Harbell
Organizations
- Letterman Army Hospital